UNBSFUni Bio Science Group, Ltd.
Price Chart
Loading chart...
About Uni Bio Science Group, Ltd. (UNBSF)
Uni Bio Science Group, Ltd. (UNBSF) is a Biotechnology company headquartered in New Territories, HK, China whose shares trade over-the-counter on the Pink tier.
Uni-Bio Science Group Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company operates through four segments. In-house Chemical Pharmaceutical Products segment is engaged in the manufacture and sales of in-house chemical pharmaceutical products. Its chemical pharmaceutical products include Pinapu, among others. In-house Biological Pharmaceutical Products segment is engaged in the manufacture and sales of in-house biological pharmaceutical products. Its biological pharmaceutical products include GeneTime and GeneSoft, among others. In-house Biological Pipeline segment is engaged in the industrialization of in-house biological pipeline. Its biological pipeline products include Uni-E4 and Uni-PTH, among others. Third-party Pharmaceutical Products segment is engaged in the sales of third-party pharmaceutical products.
UNBSF key facts
- Ticker symbol
- UNBSF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- New Territories, HK, China
- Estimated market cap
- $25.46M (as of May 14, 2025)
- Shares outstanding
- 6,364,768,000
- Reporting standard
- International Reporting: Hong Kong Stock Exchange
- Audit status
- Unaudited
- Fiscal year end
- 12/31
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with U
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Uni Bio Science Group, Ltd. (UNBSF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Social Media
Business Details
Stock Details
Loading modules...